RNA
#3517
Atrium Therapeutics, Inc. - Common Stock
13.6 4 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.43%
Variación mensual
+20.39%
Variación en los últimos 6 meses
-1.23%
Cambio anual
-80.61%
Cierres anteriores
13.9 8
Open
13.6 4
Mínimo
13.6 4
Máximo
13.6 4
Volumen
20
Financials
- Market Capitalization 233.32 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnología
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3487 |  CLLS Cellectis S.A. - American Depositary Shares | 3.40 USD | -3.13% | +5.26% | +20.57% | +32.30% | 243.95 M USD | ||
| 3492 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.29 USD | -1.29% | -2.14% | +31.61% | +2.23% | 241.28 M USD | ||
| 3519 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.59 USD | +0.22% | +5.43% | +44.11% | -9.46% | 233.08 M USD | ||
| 3529 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.84 USD | -5.65% | +1.04% | +17.48% | +105.96% | 231.10 M USD |